Cargando…

Renal cell carcinoma: the population, real world, and cost-of-illness

BACKGROUND: The RCC treatment landscape has evolved dramatically over the past decade. The purpose of this study is to present a real-world data estimation of RCC’s cost-of-illness for this tumour’s clinical pathway. METHODS: This investigation is a population-based cohort study using real-world dat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Buja, Alessandra, De Luca, Giuseppe, Gatti, Maura, Cozzolino, Claudia, Rugge, Massimo, Zorzi, Manuel, Gardi, Mario, Sepulcri, Matteo, Bimbatti, Davide, Baldo, Vincenzo, Maruzzo, Marco, Basso, Umberto, Zagonel, Vittorina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9764745/ https://www.ncbi.nlm.nih.gov/pubmed/36536329 http://dx.doi.org/10.1186/s12894-022-01160-y

Ejemplares similares

Nivolumab drug holiday in patients treated for metastatic renal cell carcinoma: A real-world, single-centre experience
por: Bimbatti, Davide, et al.
Publicado: (2022)

Patient Reported Outcomes, Paternity, Relationship, and Fertility in Testicular Cancer Survivors: Results from a Prospective Observational Single Institution Trial
por: Bimbatti, Davide, et al.
Publicado: (2022)

Tumour Seeding After a Thoracic Biopsy for Renal Cell Carcinoma: A Case Report and a Review of the Literature
por: Michele, Dionese, et al.
Publicado: (2021)

Neoadjuvant sirolimus for a large hepatic perivascular epithelioid cell tumor (PEComa)
por: Bergamo, Francesca, et al.
Publicado: (2014)

Prognostic Stratification of Metastatic Prostate Cancer Patients Treated With Abiraterone and Enzalutamide Through an Integrated Analysis of Circulating Free microRNAs and Clinical Parameters
por: Sharova, Evgeniya, et al.
Publicado: (2021)

Real-World Treatment with Nivolumab or Cabozantinib for Metastatic Renal Cell Carcinoma (mRCC) in the Veneto Region of Italy: Results of AMOUR Study
por: Maruzzo, Marco, et al.
Publicado: (2022)

Malignant Melanoma: Direct Costs by Clinical and Pathological Profile
por: Buja, Alessandra, et al.
Publicado: (2022)

Epidemiology, pathological characteristics and survival of retroperitoneal soft‑tissue sarcomas compared with non‑retroperitoneal soft tissue sarcomas
por: Buja, Alessandra, et al.
Publicado: (2023)

Trabectedin Drug Holiday and Rechallenge in Soft Tissue Sarcomas: Report of 4 Cases and Literature Review
por: Pierantoni, Francesco, et al.
Publicado: (2019)

Advanced Non-Clear Cell Renal Cell Carcinoma Treatments and Survival: A Real-World Single-Centre Experience
por: Bimbatti, Davide, et al.
Publicado: (2023)

Direct Costs of Care for Adults with Soft Tissue Sarcomas: A Population-Based Study
por: Rugge, Massimo, et al.
Publicado: (2022)

Sex Differences in Cutaneous Melanoma: Incidence, Clinicopathological Profile, Survival, and Costs
por: Buja, Alessandra, et al.
Publicado: (2022)

Cutaneous Melanoma in Alpine Population: Incidence Trends and Clinicopathological Profile
por: Buja, Alessandra, et al.
Publicado: (2022)

Prognostic role of systemic inflammation indexes in metastatic urothelial carcinoma treated with immunotherapy
por: Dionese, Michele, et al.
Publicado: (2023)

Health Outcomes and Direct Healthcare Costs in Patients with Melanoma: Associations with Level of Education
por: BUJA, Alessandra, et al.
Publicado: (2020)

Adjuvant chemotherapy for soft tissue sarcomas: a 10-year mono-institutional experience
por: Brunello, Antonella, et al.
Publicado: (2015)

Use of an Artificial Neural Network to Identify Patient Clusters in a Large Cohort of Patients with Melanoma by Simultaneous Analysis of Costs and Clinical Characteristics
por: DAMIANI, Giovanni, et al.
Publicado: (2020)

Health and healthcare variables associated with Italy's excess mortality during the first wave of the COVID-19 pandemic: An ecological study
por: Buja, Alessandra, et al.
Publicado: (2022)

Prognosis for Cutaneous Melanoma by Clinical and Pathological Profile: A Population-Based Study
por: Buja, Alessandra, et al.
Publicado: (2021)

Cost items in melanoma patients by clinical characteristics and time from diagnosis
por: Buja, Alessandra, et al.
Publicado: (2023)

Is emotional eating associated with behavioral traits and Mediterranean diet in children? A cross-sectional study
por: Buja, Alessandra, et al.
Publicado: (2022)

Clinical performance indicators for monitoring the management of cutaneous melanoma: a population-based perspective
por: Buja, Alessandra, et al.
Publicado: (2022)

Sex Differences in Soft Tissue Sarcoma: Incidence, Clinicopathological Profile, Survival, and Costs
por: Buja, Alessandra, et al.
Publicado: (2023)

Indicators of clinical performance in monitoring soft tissue sarcoma management: a population-based perspective
por: Rugge, Massimo, et al.
Publicado: (2023)

Targeted therapies in metastatic gastric cancer: Current knowledge and future perspectives
por: Pellino, Antonio, et al.
Publicado: (2019)

Prognostic Value of Thyroid Hormone Ratio in Patients With Advanced Metastatic Renal Cell Carcinoma: Results From the Threefour Study (Meet-URO 14)
por: Maruzzo, Marco, et al.
Publicado: (2021)

Clinical experience and critical evaluation of the role of sorafenib in renal cell carcinoma
por: Zustovich, Fable, et al.
Publicado: (2011)

Demographic and socio-economic factors, and healthcare resource indicators associated with the rapid spread of COVID-19 in Northern Italy: An ecological study
por: Buja, Alessandra, et al.
Publicado: (2020)

Is adherence to the Mediterranean diet associated with good sleep duration in primary-school children?
por: Buja, Alessandra, et al.
Publicado: (2022)

Caring for Patients with Advanced Stage Cancer at the Time of COVID‐19
por: Brunello, Antonella, et al.
Publicado: (2020)

The Overall Survival and Progression-Free Survival in Patients with Advanced Adrenocortical Cancer Is Increased after the Multidisciplinary Team Evaluation
por: Tizianel, Irene, et al.
Publicado: (2022)

Treatment with checkpoint inhibitors in a metastatic colorectal cancer patient with molecular and immunohistochemical heterogeneity in MSI/dMMR status
por: Loupakis, Fotios, et al.
Publicado: (2019)

Cost‐effectiveness analysis of the new oncological drug durvalumab in Italian patients with stage III non‐small cell lung cancer
por: Buja, Alessandra, et al.
Publicado: (2022)

Impressive reduction of brain metastasis radionecrosis after cabozantinib therapy in metastatic renal carcinoma: A case report and review of the literature
por: Lolli, Jacopo, et al.
Publicado: (2023)

Corrigendum: Impressive reduction of brain metastasis radionecrosis after cabozantinib therapy in metastatic renal carcinoma: a case report and review of the literature
por: Lolli, Jacopo, et al.
Publicado: (2023)

To Transplant or Not to Transplant During the SARS‐CoV‐2 Pandemic? That Is the Question
por: Marino, Dario, et al.
Publicado: (2020)

Machine learning to predict overall short-term mortality in cutaneous melanoma
por: Cozzolino, C., et al.
Publicado: (2023)

Management and Outcomes of Older Patients (Age ≥ 70 Years) with Advanced Soft Tissue Sarcoma and Role of Geriatric Assessment and Oncological Multidimensional Prognostic Index (Onco-MPI) in a Real-World Setting
por: Chiusole, Benedetta, et al.
Publicado: (2023)

How does it work? Factors involved in telemedicine home-interventions effectiveness: A review of reviews
por: Bertoncello, Chiara, et al.
Publicado: (2018)

Breast Cancer Primary Prevention and Diet: An Umbrella Review
por: Buja, Alessandra, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_omn56aa5uk3gtk4s49cm4j4lo4